1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Neurology Diagnostic and Monitoring Devices Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Neurology Diagnostic and Monitoring Devices Market Analysis and Forecasts, 2017 – 2031
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
5.2. Key Vendor and Distributor Analysis
5.3. Evolving Trends in Medical Imaging Services
5.4. Winning Imperatives, by Key Players
5.5. Growing Adoption of Remote Monitoring Technology, by Medical Imaging Service Providers
5.6. Technological Advancements
6. Global Neurology Diagnostic and Monitoring Devices Market Analysis and Forecasts, By Device Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Device Type, 2017 – 2031
6.3.1. Electroencephalogram (EEG) Systems
6.3.2. Magnetic Resonance Imaging (MRI) Systems
6.3.3. Computed Tomography (CT) Scanner
6.3.4. Position emission tomography (PET) System
6.3.5. Ultrasound Imaging Systems
6.3.6. Others
6.4. Market Attractiveness By Device Type
7. Global Neurology Diagnostic and Monitoring Devices Market Analysis and Forecasts, By Indication
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Indication, 2017 – 2031
7.3.1. Neurodegenerative Disease
7.3.2. Epilepsy
7.3.3. Stroke
7.3.4. Others
7.4. Market Attractiveness By Indication
8. Global Neurology Diagnostic and Monitoring Devices Market Analysis and Forecasts, By End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By End-user, 2017 – 2031
8.3.1. Hospitals and Surgery Centers
8.3.2. Neurology Centers
8.3.3. Ambulatory Care Centers
8.3.4. Diagnostic Laboratories & Imaging Centers
8.3.5. Research Laboratories & Academic Institutes
8.4. Market Attractiveness By End-user
9. Global Neurology Diagnostic and Monitoring Devices Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America Neurology Diagnostic and Monitoring Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Device Type, 2017 – 2031
10.2.1. Electroencephalogram (EEG) Systems
10.2.2. Magnetic Resonance Imaging (MRI) Systems
10.2.3. Computed Tomography (CT) Scanner
10.2.4. Position emission tomography (PET) System
10.2.5. Ultrasound Imaging Systems
10.2.6. Others
10.3. Market Value Forecast By Indication, 2017 – 2031
10.3.1. Neurodegenerative Disease
10.3.2. Epilepsy
10.3.3. Stroke
10.3.4. Others
10.4. Market Value Forecast By End-user, 2017 – 2031
10.4.1. Hospitals and Surgery Centers
10.4.2. Neurology Centers
10.4.3. Ambulatory Care Centers
10.4.4. Diagnostic Laboratories & Imaging Centers
10.4.5. Research Laboratories & Academic Institutes
10.5. Market Value Forecast By Country, 2017 – 2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Device Type
10.6.2. By Indication
10.6.3. By End-user
10.6.4. By Country
11. Europe Neurology Diagnostic and Monitoring Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Device Type, 2017 – 2031
11.2.1. Electroencephalogram (EEG) Systems
11.2.2. Magnetic Resonance Imaging (MRI) Systems
11.2.3. Computed Tomography (CT) Scanner
11.2.4. Position emission tomography (PET) System
11.2.5. Ultrasound Imaging Systems
11.2.6. Others
11.3. Market Value Forecast By Indication, 2017 – 2031
11.3.1. Neurodegenerative Disease
11.3.2. Epilepsy
11.3.3. Stroke
11.3.4. Others
11.4. Market Value Forecast By End-user, 2017 – 2031
11.4.1. Hospitals and Surgery Centers
11.4.2. Neurology Centers
11.4.3. Ambulatory Care Centers
11.4.4. Diagnostic Laboratories & Imaging Centers
11.4.5. Research Laboratories & Academic Institutes
11.5. Market Value Forecast By Country, 2017 – 2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Device Type
11.6.2. By Indication
11.6.3. By End-user
11.6.4. By Country
12. Asia Pacific Neurology Diagnostic and Monitoring Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Device Type, 2017 – 2031
12.2.1. Electroencephalogram (EEG) Systems
12.2.2. Magnetic Resonance Imaging (MRI) Systems
12.2.3. Computed Tomography (CT) Scanner
12.2.4. Position emission tomography (PET) System
12.2.5. Ultrasound Imaging Systems
12.2.6. Others
12.3. Market Value Forecast By Indication, 2017 – 2031
12.3.1. Neurodegenerative Disease
12.3.2. Epilepsy
12.3.3. Stroke
12.3.4. Others
12.4. Market Value Forecast By End-user, 2017 – 2031
12.4.1. Hospitals and Surgery Centers
12.4.2. Neurology Centers
12.4.3. Ambulatory Care Centers
12.4.4. Diagnostic Laboratories & Imaging Centers
12.4.5. Research Laboratories & Academic Institutes
12.5. Market Value Forecast By Country, 2017 – 2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Device Type
12.6.2. By Indication
12.6.3. By End-user
12.6.4. By Country
13. Latin America Neurology Diagnostic and Monitoring Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Device Type, 2017 – 2031
13.2.1. Electroencephalogram (EEG) Systems
13.2.2. Magnetic Resonance Imaging (MRI) Systems
13.2.3. Computed Tomography (CT) Scanner
13.2.4. Position emission tomography (PET) System
13.2.5. Ultrasound Imaging Systems
13.2.6. Others
13.3. Market Value Forecast By Indication, 2017 – 2031
13.3.1. Neurodegenerative Disease
13.3.2. Epilepsy
13.3.3. Stroke
13.3.4. Others
13.4. Market Value Forecast By End-user, 2017 – 2031
13.4.1. Hospitals and Surgery Centers
13.4.2. Neurology Centers
13.4.3. Ambulatory Care Centers
13.4.4. Diagnostic Laboratories & Imaging Centers
13.4.5. Research Laboratories & Academic Institutes
13.5. Market Value Forecast By Country, 2017 – 2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Device Type
13.6.2. By Indication
13.6.3. By End-user
13.6.4. By Country
14. Middle East & Africa Neurology Diagnostic and Monitoring Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Device Type, 2017 – 2031
14.2.1. Electroencephalogram (EEG) Systems
14.2.2. Magnetic Resonance Imaging (MRI) Systems
14.2.3. Computed Tomography (CT) Scanner
14.2.4. Position emission tomography (PET) System
14.2.5. Ultrasound Imaging Systems
14.2.6. Others
14.3. Market Value Forecast By Indication, 2017 – 2031
14.3.1. Neurodegenerative Disease
14.3.2. Epilepsy
14.3.3. Stroke
14.3.4. Others
14.4. Market Value Forecast By End-user, 2017 – 2031
14.4.1. Hospitals and Surgery Centers
14.4.2. Neurology Centers
14.4.3. Ambulatory Care Centers
14.4.4. Diagnostic Laboratories & Imaging Centers
14.4.5. Research Laboratories & Academic Institutes
14.5. Market Value Forecast By Country, 2017 – 2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Device Type
14.6.2. By Indication
14.6.3. By End-user
14.6.4. By Country
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2022)
15.3. Company Profiles
15.3.1. GE Healthcare
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Neurosoft
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Canon Medical Systems Corporation (Canon, Inc.)
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Fujifilm Holding Corporation
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Koninklijke Philips N.V.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Siemens Healthineers AG
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Shimadzu Corporation
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. United Imaging Healthcare Co., Ltd.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Hologic, Inc.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Esaote SpA
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
